Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program

Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program

Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include increased incidence of diabetes. Here we describe the temporal relationship between new type 2 diabetes and SARS-CoV-2 infection in a nationwide database. We found that while the proportion of newly diagn...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Neha V. Reddy, Hsin-Chieh Yeh, Jena S. Tronieri, Til Stürmer, John B. Buse, Jane E. Reusch, Steven G. Johnson, Rachel Wong, Richard Moffitt, Kenneth J. Wilkins, Jeremy Harper, Carolyn T. Bramante, the N3C and RECOVER Consortiums
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Cambridge University Press 2023-01-01
Sraith:Journal of Clinical and Translational Science
Ábhair:
COVID-19
epidemiology
PASC
type 2 diabetes
new diabetes
Rochtain ar líne:https://www.cambridge.org/core/product/identifier/S2059866123000341/type/journal_article
Cur síos
Achoimre:Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include increased incidence of diabetes. Here we describe the temporal relationship between new type 2 diabetes and SARS-CoV-2 infection in a nationwide database. We found that while the proportion of newly diagnosed type 2 diabetes increased during the acute period of SARS-CoV-2 infection, the mean proportion of new diabetes cases in the 6 months post-infection was about 83% lower than the 6 months preinfection. These results underscore the need for further investigation to understand the timing of new diabetes after COVID-19, etiology, screening, and treatment strategies.
ISSN:2059-8661

Míreanna comhchosúla